Detalhe da pesquisa
1.
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Pediatr Blood Cancer
; 71(6): e30976, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577760
2.
Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death.
Exp Cell Res
; 422(1): 113412, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370852
3.
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.
Cancer Sci
; 114(5): 1898-1911, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661413
4.
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
BMC Cancer
; 23(1): 313, 2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020276
5.
Comparative epigenomics by machine learning approach for neuroblastoma.
BMC Genomics
; 23(1): 852, 2022 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572864
6.
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.
Cancer Sci
; 113(2): 587-596, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807483
7.
Polycomb EZH1 regulates cell cycle/5-fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.
Cancer Sci
; 113(12): 4193-4206, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052716
8.
Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS.
J Pediatr Hematol Oncol
; 44(3): e779-e781, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001057
9.
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Int J Clin Oncol
; 25(9): 1744-1745, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749556
10.
TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
Biochem Biophys Res Commun
; 518(2): 311-318, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427086
11.
PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma.
Mol Carcinog
; 58(3): 426-435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457174
12.
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Int J Clin Oncol
; 23(5): 965-973, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700636
13.
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
J Hum Genet
; 62(1): 15-24, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439682
14.
Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Gynecol Oncol
; 144(2): 377-383, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939411
15.
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3ß resulting in the stabilization of MYCN in human neuroblastomas.
PLoS Genet
; 10(1): e1003996, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391509
16.
Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells.
Biochem Biophys Res Commun
; 478(1): 81-86, 2016 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27453342
17.
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma.
Cancer Sci
; 106(6): 766-771, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827934
18.
Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
Cancer Sci
; 106(7): 840-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880909
19.
Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
Cancer Sci
; 106(10): 1351-61, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26190440
20.
Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
Cancer Sci
; 106(4): 421-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25611295